Showing results (161-170 of 233) with videos related to

Sort By:
Pageof 24
Clinical Hematology International|January 7, 2025
Incidence and impact of other malignancies after immunochemotherapy by fludarabine, cyclophosphamide, and rituximab as frontline treatment for chronic lymphocytic leukemia: A single-center retrospective studyNicolas Stocker, Tamim Alsuliman, Elise Corre, et al.
Haematologica|December 8, 2018
Generation of anti-idiotypic antibodies to detect anti-spacer antibody idiotopes in acute thrombotic thrombocytopenic purpura patientsAn-Sofie Schelpe, Elien Roose, Bérangère S Joly, et al.
Journal of Thrombosis and Haemostasis : JTH|September 11, 2020
ISTH guidelines for the diagnosis of thrombotic thrombocytopenic purpuraX Long Zheng, Sara K Vesely, Spero R Cataland, et al.
The New England Journal of Medicine|January 10, 2019
Caplacizumab Treatment for Acquired Thrombotic Thrombocytopenic PurpuraMarie Scully, Spero R Cataland, Flora Peyvandi, et al.
Blood Advances|August 8, 2025
Trp1250, Lys1252 and Arg1367 of ADAMTS13 comprise a hot-spot for anti-CUB domain antibodies in patients with iTTPTim Postmus, Robin Jansen, Paul Kaijen, et al.
Intensive Care Medicine|October 22, 2023
Magnesium sulphate in patients with thrombotic thrombocytopenic purpura (MAGMAT): a randomised, double-blind, superiority trialLara Zafrani, Emmanuel Canet, Anouk Walter-Petrich, et al.
American Journal of Respiratory and Critical Care Medicine|September 15, 2016
Epidemiology of Weaning Outcome according to a New Definition. The WIND StudyGaëtan Béduneau, Tài Pham, Frédérique Schortgen, et al.
British Journal of Clinical Pharmacology|November 6, 2018
Thrombotic microangiopathy associated with gemcitabine use: Presentation and outcome in a national French retrospective cohortFlorence Daviet, Franck Rouby, Pascale Poullin, et al.
Leukemia & Lymphoma|October 4, 2017
Autoimmune manifestations associated with lymphoma: characteristics and outcome in a multicenter retrospective cohort studyVincent Jachiet, Arsène Mekinian, Fabrice Carrat, et al.
Blood Advances|September 8, 2021
Anti-ADAMTS13 autoantibody profiling in patients with immune-mediated thrombotic thrombocytopenic purpuraKadri Kangro, Elien Roose, Bérangère S Joly, et al.
Pageof 24